Crispr Therapeutics shares owned by Royal Bank of Canada
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Royal Bank of Canada
from 13F filings
Historical chart of Royal Bank of Canada investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by Royal Bank of Canada consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crispr Therapeutics by Royal Bank of Canada
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $5.7M | 90k | 62.60 |
| 2023-09-30 | $4.4M | 97k | 45.36 |
| 2023-06-30 | $5.5M | 99k | 55.73 |
| 2022-12-31 | $4.0M | 100k | 40.32 |
| 2022-09-30 | $8.8M | 134k | 65.52 |
| 2021-06-30 | $38M | 236k | 162.30 |
| 2021-03-31 | $28M | 230k | 121.85 |
| 2020-12-31 | $34M | 222k | 153.11 |
| 2020-09-30 | $17M | 203k | 83.59 |
| 2020-06-30 | $13M | 179k | 73.43 |
| 2020-03-31 | $4.9M | 115k | 42.41 |
| 2019-12-31 | $6.6M | 108k | 60.90 |
| 2019-09-30 | $4.3M | 106k | 40.99 |
| 2019-03-31 | $2.5M | 69k | 35.72 |
| 2018-12-31 | $1.7M | 60k | 28.56 |
| 2018-09-30 | $3.4M | 77k | 44.35 |
| 2018-06-30 | $3.2M | 54k | 58.75 |
| 2018-03-31 | $1.2M | 27k | 45.74 |
| 2017-12-31 | $326k | 14k | 23.47 |